Inhibition of EGFR-AKT Axis Results in the Suppression of Ovarian Tumors in Vitro and in Preclinical Mouse Model

PLoS ONE - United States
doi 10.1371/journal.pone.0043577
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2011English

Inhibition of Hemangioma Development in a Syngeneic Mouse Model Correlates With BCL-2 Suppression and the Inhibition of Akt Kinase Activity

Angiogenesis
Cancer ResearchClinical BiochemistryPhysiology
2011English

Human Ovarian Tumors of Epithelial Origin Express PDGF in Vitro and in Vivo

Cancer Genetics and Cytogenetics
1994English

SKA3 Promotes Lung Adenocarcinoma Metastasis Through the EGFR-PI3K-Akt Axis

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

EGFR Inhibition Prevents in Vitro Tumor Growth of Salivary Adenoid Cystic Carcinoma

BMC Cell Biology
Cell Biology
2013English

Lidocaine Inhibits the Progression of Retinoblastoma In�vitro and In�vivo by Modulating the miR‑520a‑3p/EGFR Axis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Tankyrase Inhibition Enhances the Anti-Proliferative Effect of PI3K and EGFR Inhibition, Mutually Affecting Β-Catenin and AKT Signaling in Colorectal Cancer

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2017English

CXCR2 Inhibition Combined With Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer

PLoS ONE
Multidisciplinary
2015English

Targeting of Both the C-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice

Cancers
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy